Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Myeloproliferative Neoplasms ORLANDO, ...

We are thrilled to welcome leaders of Sherwin and Becker’s caliber to the executive team at Galecto,” said Hans Schambye, Ph.D., Chief Executive Officer of Galecto. “Their extensive experience in drug ...

She recently delivered the keynote address at the inaugural Blood Cancer Heroes celebration, held in partnership with Blood ...

Patients with SSc were linked to an increased risk for hematological malignancies, specifically B-cell malignancies.

CK0804, a novel Treg therapy, gains FDA orphan drug status for myelofibrosis, promising new hope for patients with limited treatment options. CK0804, an investigational allogeneic regulatory T cell ...

Takeda and Protagonist Therapeutics have submitted a new drug application to the FDA for rusfertide for adults with ...

Investigators describe this as the largest study to date linking thromboinflammation biomarkers with thrombosis risk in myeloproliferative neoplasms.

We’ve seen the first AI-generated commercials, songs and even social media influencers outside of healthcare. Will pharma be ...

TATIANA Schlossberg, the granddaughter of former US president John F. Kennedy, has died of cancer aged just 35. The news came ...

Preliminary but promising.Those three words emerged as a recurring theme in conversations about several abstracts presented at this year’s ASH Annual Meeting and Exposition that examined the effects ...

Atavistik Bio is led by an experienced team of drug hunters with a proven track record of developing marketed small molecule therapies and supported by top-tier investors, including The Column Group, ...

BOSTON, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (the “Company” or “Galecto”) (Nasdaq: GLTO) today announced that the Company’s Board of Directors approved the grant of non-qualified stock ...